Workflow
募集资金管理
icon
Search documents
久盛电气: 募集资金管理制度
Zheng Quan Zhi Xing· 2025-06-19 08:22
久盛电气股份有限公司 第一条 为了规范久盛电气股份有限公司(以下简称"公司")募集资金的管 理和运用,保护投资者的权益,依照《中华人民共和国公司法》《中华人民共和 国证券法》《首次公开发行股票注册管理办法》《上市公司证券发行注册管理办 法》《深圳证券交易所创业板股票上市规则》(以下简称《上市规则》)《深圳 证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》(以下 简称《规范运作指引》)《上市公司募集资金监管规则》等法律法规的规定和《久 盛电气股份有限公司章程》(以下简称《公司章程》),结合公司实际情况,特 制定本制度。 第二条 本制度所称募集资金是指公司通过发行股票及其衍生品种(包括首 次公开发行股票、配股、增发、发行可转换公司债券、分离交易的可转换公司债 券、权证等),向投资者募集并用于特定用途的资金,不包括公司为实施股权激 励计划募集的资金。 第三条 公司董事会负责建立健全募集资金管理制度,并确保本制度的有效 实施。 募集资金投资项目(以下简称"募投项目")通过公司的子公司或公司控制 的其他企业实施的,公司确保该子公司或公司控制的其他企业也应遵守本制度。 第四条 公司董事会应当对募投项目 ...
天风证券股份有限公司 关于签订募集资金三方监管协议的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意天风证券股份有限公司向特定对象发行股票注册的批复》(证监 许可〔2025〕1164号)同意,天风证券股份有限公司(以下简称"公司")向特定对象发行A股股票 1,476,014,760股,每股发行价格为人民币2.71元,募集资金总额人民币3,999,999,999.60元,扣除不含税 发行费用人民币18,833,000.69元,公司实际募集资金净额为人民币3,981,166,998.91元。截至2025年6月 12日,募集资金已足额划至公司本次发行募集资金专户。2025年6月12日,大信会计师事务所(特殊普 通合伙)出具了《天风证券股份有限公司向特定对象发行A股股票募集资金到位情况验资报告》(大信 验字[2025]-00005号)。 二、《募集资金专户存储三方监管协议》的签订情况和募集资金专户的开立情况 ■ 注:表中募集资金专户存储金额包括部分尚未支付的发行费用。 三、《募集资金专户存储三方监管协议》的主要内容 协议约定的主要 ...
科思科技: 中天国富证券有限公司关于深圳市科思科技股份有限公司2024年年度报告的信息披露监管问询函的核查意见
Zheng Quan Zhi Xing· 2025-06-18 12:26
Core Viewpoint - The company is facing significant challenges regarding its cash flow management and project funding, particularly with a substantial portion of its bank accounts being frozen, which has raised concerns about its liquidity and operational efficiency [1][6][9]. Group 1: Cash Management and Financial Status - As of the end of 2024, the company's cash balance was 735 million yuan, a decrease of 45.11% year-on-year, primarily due to investments in time deposits that had not matured [1]. - The company reported that 527 million yuan of its funds, representing 71.66% of its audited cash balance, were frozen across various bank accounts [1][6]. - The company has converted part of its cash into time deposits, totaling 1.026 billion yuan, with no pledges or restrictions on these deposits, indicating a strategic approach to cash management [2][3]. Group 2: Short-term Debt and Cash Flow - The company's short-term liabilities primarily consist of accounts payable and employee compensation, with a total of 139.23 million yuan in short-term debt, suggesting manageable short-term repayment pressure [4]. - The net cash flow from operating activities for 2024 was negative 70.51 million yuan, indicating that the company's operational expenditures exceeded its cash inflows [5]. - The company has maintained that its remaining cash, after accounting for time deposits and guarantees, is sufficient to cover its operational needs, including purchasing raw materials and paying salaries [4][5]. Group 3: Project Funding and Investment Progress - The company raised a total of 2 billion yuan in its initial public offering, with a cumulative investment progress of 53.85% as of the reporting period, indicating slower-than-expected deployment of funds [9][21]. - The "Electronic Information Equipment Production Base Construction Project" has not yet received any funding, primarily due to delays in securing land and property for the project [12][13]. - The company has adjusted the project location to Nanjing and extended the construction period to December 2026, reflecting a strategic response to external challenges [9][13]. Group 4: Compliance and Governance - The company has conducted internal investigations to ensure that there are no illegal activities by its directors or senior management that could have led to the freezing of funds, confirming compliance with regulatory requirements [7][9]. - The company has disclosed the freezing of its bank accounts in a timely manner, adhering to the information disclosure obligations set by the Shanghai Stock Exchange [8][9].
赛伦生物: 赛伦生物:关于部分募集资金投资项目结项并将节余募集资金永久补充流动资金以及注销相关募集资金专户的公告
Zheng Quan Zhi Xing· 2025-06-18 10:21
证券代码:688163 证券简称:赛伦生物 公告编号:2025-015 上海赛伦生物技术股份有限公司 关于部分募集资金投资项目结项并将节余募集资金 永久补充流动资金以及注销相关募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 上海赛伦生物技术股份有限公司(以下简称"公司")首次公开发行股票募 投项目"急(抢)救药物急救网络服务项目"已完成建设并达到预定可使用状态, 公司决定将其结项后的节余募集资金永久补充流动资金,同时注销相关募集资金 专户。现将具体情况公告如下: 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海赛伦生物技术股份有限公司首 次公开发行股票注册的批复》(证监许可【2022】204 号)的批准,公司获准向 社会公开发行人民币普通股 2,706 万股,每股面值为 1.00 元,每股发行价格为 元,募集资金净额为 78,492.36 万元。上述募集资金已于 2022 年 3 月 4 日全部到 位,并存放于募集资金专项账户内。天职国际会计师事务所(特殊普通合伙)于 资金实施专户存储、专 ...
格力博: 关于提前归还暂时补充流动资金的闲置募集资金的公告
Zheng Quan Zhi Xing· 2025-06-18 08:20
Core Viewpoint - Greebo (Jiangsu) Co., Ltd. has announced the early repayment of idle raised funds that were temporarily used to supplement working capital, ensuring that the use of these funds did not affect the progress of the fundraising investment projects [1][2]. Group 1 - The company approved the use of up to RMB 1.2 billion (120,000 million) of idle raised funds to temporarily supplement its working capital, with a usage period not exceeding 12 months [1]. - The actual amount used for temporary working capital was RMB 1.2 billion, which was returned to the special account for raised funds before the end of the 12-month period [2]. - The company ensured that the idle raised funds were only used for activities related to its main business, and there was no change in the purpose of the raised funds or any harm to shareholder interests [2].
大中矿业: 关于签订募集资金四方监管协议的公告
Zheng Quan Zhi Xing· 2025-06-17 12:21
证券代码:001203 证券简称:大中矿业 公告编号:2025-068 债券代码:127070 债券简称:大中转债 大中矿业股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 近日,大中矿业股份有限公司(以下简称"公司")、公司全资子公司湖南 大中赫锂矿有限责任公司(以下简称"湖南大中赫")、兴业银行股份有限公司 郴州分行、国都证券股份有限公司(以下简称"国都证券")共同签订了《募集 资金四方监管协议》。具体情况如下: 一、募集资金基本情况 湖南大中赫已完成上述募集资金专项账户的开设,并且公司、湖南大中赫、 国都证券、兴业银行股份有限公司郴州分行已签订了《募集资金四方监管协议》。 募集资金专项账户开设和存储情况如下: | | | 募集资金专户 | 募集资金储蓄 | | | | --- | --- | --- | --- | --- | --- | | 序号 | 开户主体 | 开户银行 | | 募集资金用途 | | | | | 账号 | 金额(万元) | | | | | 湖南大中赫 | 兴业银行股份 | | 2000 年处理 | 万吨多 | 任公司 分 ...
长华化学: 东吴证券股份有限公司关于长华化学科技股份有限公司部分募投项目增加实施主体及实施地点并授权办理募集资金专户有关事项的核查意见
Zheng Quan Zhi Xing· 2025-06-17 11:25
Core Viewpoint - The company has approved the addition of a subsidiary as an implementation entity for a fundraising project, which will enhance the efficiency of fund usage and project execution without altering the original investment plan [1][7][8] Group 1: Fundraising Overview - The company issued 35.05 million shares at a price of 25.75 yuan per share, raising a total of approximately 902.54 million yuan, with net proceeds of about 524.46 million yuan after deducting related issuance costs [2] - A special account has been established for the management of the raised funds, ensuring compliance with relevant regulations and protecting investor interests [2][6] Group 2: Project Implementation Changes - The implementation entity for the "Information System Construction" project has been expanded to include the wholly-owned subsidiary, Changhua Lianyungang, alongside the company itself [5] - The project location has been updated to include both the original site in Zhangjiagang and a new site in Lianyungang [5] Group 3: Rationale for Changes - The decision to add the subsidiary as an implementation entity is based on its significant investment plans for building a green, low-carbon, and intelligent factory, which aligns with the company's operational needs and development strategy [5][7] - This change is expected to optimize the funding structure for the subsidiary, enhance project management efficiency, and improve overall governance and management levels of the company [5][7][8] Group 4: Approval Process - The board of directors and the supervisory board have reviewed and approved the changes, confirming that they fall within the board's authority and do not require shareholder approval [6][8] - The changes are in compliance with the relevant regulations set forth by the China Securities Regulatory Commission and the Shenzhen Stock Exchange [8]
爱威科技: 爱威科技关于注销部分募集资金专户的公告
Zheng Quan Zhi Xing· 2025-06-17 11:11
证券代码:688067 证券简称:爱威科技 公告编号:2025-022 爱威科技股份有限公司 为了规范募集资金的管理和使用,保护投资者权益,公司根据《上海证券交 易所科创板股票上市规则》《上市公司监管指引第 2 号——上市公司募集资金管 理和使用的监管要求》及《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关规定和要求,结合公司实际情况,制定了《募集资金管 理制度》,对募集资金的存储、使用及管理等方面做出了明确的规定,在制度上 保证募集资金的规范使用。 为规范公司募集资金管理和使用,保护投资者权益,公司设立了相关募集资 金专户。募集资金到账后,已全部存放于募集资金专户内,公司及全资子公司湖 南爱威医疗科技有限公司(以下简称"爱威医疗")已与保荐机构西部证券股份有 限公司、存放募集资金的商业银行签署了募集资金三方/四方监管协议。上述募 集资金专户存储三方/四方监管协议与上海证券交易所《募集资金专户存储三方 监管协议(范本)》不存在重大差异,公司在使用募集资金时已经严格遵照执行。 截至本公告披露日,公司募集资金专用账户开立情况如下: 一、募集资金基本情况 | 开户主体 | 开户银行 | 银行 ...
兴通海运股份有限公司第二届董事会第二十八次会议决议公告
Group 1 - The company held its 28th meeting of the second board on June 16, 2025, with all 11 directors present, and the meeting was conducted in accordance with relevant regulations [2][4] - The board approved several resolutions, including adjustments to the proposed investment amounts for fundraising projects, which do not require shareholder meeting approval [3][5][7] - The company plans to hold its second extraordinary general meeting of 2025 on July 2, 2025, to discuss various matters [11][12] Group 2 - The supervisory board also convened on June 16, 2025, with all three supervisors present, and approved similar resolutions regarding the adjustment of fundraising project amounts [13][15] - The supervisory board confirmed that the adjustments would not adversely affect the normal use of the raised funds and comply with relevant laws [14][18] Group 3 - The company announced the adjustment of the proposed investment amounts for fundraising projects, stating that the actual net fundraising amount was RMB 632,767,998.06 after deducting issuance costs [23][24] - The adjustments were made to ensure the smooth implementation of fundraising projects without changing the intended use of the funds [26][28] Group 4 - The company plans to use RMB 455,452,145.79 of the raised funds to replace pre-invested self-raised funds for fundraising projects and to cover issuance costs [34][36] - The company has established a special account for the management of raised funds to protect investor interests [24][35] Group 5 - The company will change its registered capital from RMB 280 million to RMB 325 million following the issuance of new shares [41][42] - The amendments to the company's articles of association will be submitted for shareholder approval [42] Group 6 - The company has scheduled its second extraordinary general meeting for July 2, 2025, with provisions for both on-site and online voting [45][46] - The meeting will address various resolutions that have already been approved by the board and supervisory board [47]
雅本化学: 募集资金使用管理办法(2025年6月)
Zheng Quan Zhi Xing· 2025-06-16 13:13
雅本化学股份有限公司募集资金使用管理办法 雅本化学股份有限公司 募集资金使用管理办法 第一章 总 则 第一条 为进一步规范雅本化学股份有限公司(以下简称"公司")募集资金 的管理和使用,提高募集资金使用的效率和效果,防范资金使用风险,确保资金 使用安全,切实保护投资者利益,根据《中华人民共和国公司法》、 《中华人民共 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公 和国证券法》、 司规范运作》、 《深圳证券交易所创业板股票上市规则》、 《上市公司募集资金监管 规则》、 《雅本化学股份有限公司章程》 (以下简称"《公司章程》")和其他有关法 律、法规和规范性文件的规定,结合公司实际情况,制定公司《募集资金使用管 理办法》(以下简称"本《管理办法》")。 第二条 本《管理办法》所称募集资金是指公司通过发行股票或者其他具有 股权性质的证券,向投资者募集并用于特定用途的资金,但不包括公司实施股权 激励计划募集的资金。 第三条 公司的董事、高级管理人员应当勤勉尽责,确保公司募集资金安全, 不得操控公司擅自或变相改变募集资金用途。 公司存在二次以上融资的,应当分别设置募集资金专户。 第六条 实际发行募集资 ...